NCT05658679

Brief Summary

The images of patients with pancreatic cancer were collected and analyzed based on the methodes of radiomics

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
6.9 years until next milestone

First Submitted

Initial submission to the registry

December 5, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 21, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

December 21, 2022

Status Verified

December 1, 2022

Enrollment Period

7.9 years

First QC Date

December 5, 2022

Last Update Submit

December 13, 2022

Conditions

Pancreatic Cancer

Outcome Measures

Primary Outcomes (1)

  • 5-year survival rate

    1 week

Study Arms (2)

patients with pancreatic cancer

Patients with pancreatic tumors diagnosed clinically or pathologically

Participants without pancreatic cancer

Participants who judged the pancreas to be completely healthy through medical examination

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants willing to receive abdominal imaging could be included in this study

You may qualify if:

  • Gender unlimited, 18-80 years old;
  • Received abdominal imaging;
  • informed consent signed.

You may not qualify if:

  • Pregnant / lactating women；
  • Contraindications of imaging examination。

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Fu N, Fu W, Chen H, Chai W, Qian X, Wang W, Jiang Y, Shen B. A deep-learning radiomics-based lymph node metastasis predictive model for pancreatic cancer: a diagnostic study. Int J Surg. 2023 Aug 1;109(8):2196-2203. doi: 10.1097/JS9.0000000000000469.

    PMID: 37216230DERIVED

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 5, 2022

First Posted

December 21, 2022

Study Start

January 1, 2016

Primary Completion

December 1, 2023

Study Completion

December 1, 2024

Last Updated

December 21, 2022

Record last verified: 2022-12